Low-dose naltrexone, reviewed by a provider
Explore the researchResearch Guides
Research GuidesLow-dose naltrexone in chronic pain and other conditions: reviews and studiesWhat randomized trials, observational cohorts and reviews report about low-dose naltrexone in chronic pain and other conditions, with their limits.Read guide →Research GuidesLow-dose naltrexone and Crohn's disease: what the trials and the Cochrane review measuredWhat the Cochrane review and three trials of low-dose naltrexone in Crohn's disease measured, with doses, sizes and disclosures.Read guide →Research GuidesLow-dose naltrexone and fibromyalgia: what the trials and reviews measuredWhat six fibromyalgia trials of low-dose naltrexone measured, what four reviews concluded, and the limits of both.Read guide →Research GuidesLow-dose naltrexone and multiple sclerosis: what the studies measuredWhat three published abstracts report about low-dose naltrexone in multiple sclerosis: doses, designs, sizes, dropouts and the authors' own limits.Read guide →Research GuidesNaltrexone, pregnancy and breastfeeding: what the 50 mg label saysWhat the 50 mg naltrexone label says about pregnancy, animal data and breastfeeding; it does not cover low-dose naltrexone.Read guide →Research GuidesLiver, mood and other warnings: what the 50 mg naltrexone label saysWhat the 50 mg naltrexone label says about liver injury, depression and symptoms to report; low-dose use is not covered.Read guide →Research GuidesWhat the prescribing information for naltrexone hydrochloride 50 mg tablets saysWhat the label for the 50 mg naltrexone tablet says about its use, its dosing and the opioid-free period before starting, not about low-dose use.Read guide →Research GuidesOpioids and naltrexone: what the 50 mg label and two overdose pages sayWhat the 50 mg naltrexone label says about precipitated withdrawal, overdose and opioid-containing medicines, plus two general overdose pages.Read guide →Research GuidesLow-dose naltrexone side effects: what trials, reviews and the 50 mg label reportWhat low-dose naltrexone trials, reviews and observational studies report about side effects, with the 50 mg label's figures kept separate.Read guide →Research GuidesWhat compounded low-dose naltrexone means: what the FDA says and what was testedWhat FDA pages say compounded drugs are and are not, how section 503A is described, and what two laboratory analyses of compounded capsules reported.Read guide →Research GuidesWhat low-dose naltrexone is and how it might workWhat low-dose naltrexone is, how review abstracts say it might work, and why it is an off-label use separate from the 50 mg tablet.Read guide →Research GuidesWhat off-label use means and when to see a clinicianWhat the FDA says about off-label use, what MedlinePlus and drug labels list for three conditions, and the emergency steps the sources give.Read guide →